Genentech and Breastcancer.org Say It’s "About Damn Time" We Talk About What Happens When Initial Breast Cancer Treatment Ends

Summary

Genentech and Breastcancer.org have partnered to initiate a conversation about patient experiences following initial breast cancer treatment. The announcement emphasizes the importance of addressing post-treatment patient care.